Back to discover
Disease

Pediatric Obesity

Late-stage therapeutic developmentEmerging researchRising momentum
7
Publications
24
Clinical trials
1
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Childhood obesity, metabolic syndrome, and oxidative stress: microRNAs go on stage.

Research2023-09-06Reviews in endocrine & metabolic disorders

Disordered Eating and Eating Disorders in Pediatric Obesity: Assessment and Next Steps.

Research2023-08-24International journal of environmental research and public health

Childhood obesity: Implications on adipose tissue dynamics and metabolic health.

Research2023-08-22Obesity reviews : an official journal of the International Association for the Study of Obesity

Once-Weekly Semaglutide in Adolescents with Obesity.

Research2022-11-02The New England journal of medicine

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical Milestones18View all 18
+10 more in the activity timeline below
Activity timeline18

Clinical trials

12 sponsors · 3 new · 6 completed in the last 12 months (net +2)

The current development programme across all trial phases.

Clinical programme
24
All trials
6
Active
18
Late-stage
6
Completed
Late-stage studies
Recently completed

Evidence coverage

8 treatments

How much of this condition's readable clinical evidence the confidence engine has incorporated, across its most-studied treatments. This measures coverage of the evidence base — not whether any treatment works.

Partial evidence coverage
52% · 124/240 eligible items incorporated

Largest gap: off claim endpoint family (8, endpoint-family).

Research activity

7 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20222024
Most influential

Once-Weekly Semaglutide in Adolescents with Obesity.

The New England journal of medicine · 2022 · 438 cites

Childhood obesity: Implications on adipose tissue dynamics and metabolic health.

Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023 · 16 cites

Disordered Eating and Eating Disorders in Pediatric Obesity: Assessment and Next Steps.

International journal of environmental research and public health · 2023 · 16 cites

Childhood obesity, metabolic syndrome, and oxidative stress: microRNAs go on stage.

Reviews in endocrine & metabolic disorders · 2023 · 13 cites
Recent publications
Major themes8
  • Pediatric Obesity7
  • Metabolic Syndrome2
  • Anti-Obesity Agents1
  • Biochemical Phenomena1
  • Cardiovascular Diseases1
  • Diabetes Mellitus, Type 21
  • Feeding and Eating Disorders1
  • MicroRNAs1
Leading journals6
  • International journal of environmental research and public health1
  • Italian journal of pediatrics1
  • Journal of obesity1
  • Nutrients1
  • Obesity reviews : an official journal of the International Association for the Study of Obesity1
  • Reviews in endocrine & metabolic disorders1
Leading researchers8
  • Ardianah E1
  • Arslanian S1
  • Barrett T1
  • Barrientos-Pérez M1
  • Belmonte T1
  • Bossowski A1
  • Caesar LA1
  • Calcaterra V1
Affiliations (unnormalised)6
  • "S. Maria delle Grazie" Hospital1
  • "V. Buzzi" Children's Hospital1
  • Azienda Ospedaliero-Universitaria delle Marche1
  • Bambino Gesù Children's Hospital1
  • Center of Healthy Weight and Nutrition1
  • Institut de Recerca Sant Joan de Déu1

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Pediatric obesity is excess body mass index in children and adolescents that is grossly above the recommended cutoff for age and sex. In infants younger than 2 years, it is assessed using standard weight-for-length percentile measures. The literature frames it as a common pediatric condition with important short- and long-term health consequences.

Causes

The supplied grounding supports a multifactorial etiology, but does not identify a single cause. It notes genetic and metabolic aspects in the literature, and describes excessive calorie intake as a context in which adipose tissue expands. No specific causal exposures or inherited syndromes are supported here.

Pathophysiology

The literature emphasizes adipose tissue expansion during excessive calorie intake, with changes in cellular and lipid turnover affecting adipose tissue size and metabolic status. It also links pediatric obesity with oxidative stress, inflammation, insulin disturbances, and dyslipidemia. These processes are associated with cardiometabolic complications and broader systemic effects.

Risk factors

Earlier onset of obesity is associated with longer lifetime exposure to cardiometabolic risk factors. The grounding also supports excessive calorie intake as a contributor to adiposity. Beyond that, no specific demographic, environmental, or genetic risk factors are directly supported in the supplied material.

Current standard of care

The supplied grounding supports general therapy and drug therapy as literature topics, but does not provide specific treatment recommendations. It indicates that management includes assessment of cardiometabolic risk factors and screening for disordered eating and eating disorders. No specific modality or drug class is supported strongly enough here to describe standard treatment.

AI-generated summary grounded in MeSH and 5 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

BODY MASS INDEX in children (ages 2-12) and in adolescents (ages 13-18) that is grossly above the recommended cut-off for a specific age and sex. For infants less than 2 years of age, obesity is determined based on standard weight-for-length percentile measures.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.